Colorectal Omics and OfCS Proteoglycans

Sponsor
Claus Anders Bertelsen, PhD, MD
Study ID
NCT06287671
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Colorectal resection or stoma closure — PROCEDURE
    Elective open or minimally invasive resection for colorectal cancer, IBD or other benign colorectal disorder, or stoma closure

Study Details

This observational study aims to test proteomics, metabolomics and proteoglycans as predictors of postoperative complications after colorectal surgery and as biomarkers of colorectal cancer. The main questions to answer are: * can these biomarkers predict anastomotic leakages * can these biomarkers predict recurrence after colorectal cancer * can these biomarkers be used as diagnostic tests for colorectal cancer * can these biomarkers be identified in the tumor Participants will undergo elective colorectal resection or stoma closure.

Key Dates

First listed
Mar 1, 2024
Start date
Oct 8, 2024
Status verified
Dec 2024
Primary completion
Dec 31, 2028
Completion
Dec 31, 2032

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Study cohort
    Patients undergoing elective colorectal resection or stoma closure

Primary Outcome Measure

Rate of anastomotic leakage diagnosed by CT-scan or reoperation [ Time Frame: 30 days ]

Central Contacts

Find similar trials

Nationwide
Colorectal cancer trialsOncology trialsGI oncology trials

Related Studies